Keyword: Mayne Pharma


Mayne scoops up 42 meds from Teva/Allergan in $652M deal

Teva’s massive deal to buy Allergan’s generics business continues to ripple its way through the industry. Australia’s Mayne Pharma has scooped up 42 products from the two companies for $652 million, leaping 50 spots in the U.S. generics scene into the top 25 biggest players.